Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.4.48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Xinlei Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Medical College, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Genetic Therapy, Glaucoma, Dependovirus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Qingdao Medical College, Qingdao University, Qingdao, China.
- Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
- School of Ophthalmology, Shandong First Medical University, Qingdao, China.
- State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Qingdao, China.
Zitieren
APA
Zhu, X., Qi, B., Ren, Z., Cong, L., Pan, X., Zhou, Q., Zhang, B. N., & Xie, L. (2025). Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.4.48
Vancouver
Zhu X, Qi B, Ren Z, Cong L, Pan X, Zhou Q, et al. Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.4.48
BibTeX
@article{Zhu2025,
author = {Zhu, Xinlei and Qi, Benxiang and Ren, Zhongmei and Cong, Lin and Pan, Xiaojing and Zhou, Qingjun and Zhang, Bi Ning and Xie, Lixin},
title = {Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.4.48}
}
EUVIMED